CORT

#1303
Corcept Therapeutics Inc.
35.7000
+3.13%
Settore:
Base:
Valuta di Profitto:
Intervallo Giornaliero
35.7000
35.7000
Intervallo Annuale
28.6601
89.0000
Variazione giornaliera
+3.13%
Variazione Mensile
-22.83%
Variazione di 6 mesi
-51.34%
Variazione Annuale
-51.34%
Chiusura Precedente
34.6150
Open
35.7000
Bid
Ask
Low
35.7000
High
35.7000
Volume
111
Open full chart

Financials

Overview Estratto Conto Statistics Dividends
Quarterly Annual
Income statement Balance sheet Cash flow
Value 202020212022202320242025 TTM

Corcept Therapeutics Incorporated

Corcept Therapeutics Inc. is a pharmaceutical company engaged in the discovery, development and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncologic disorders. Corcept has focused on the adverse effects of excess cortisol, studying new compounds that may mitigate those effects. Its executive team is headed by CEO, president and director Joseph K. Belanoff, MD.

Notizie